April 24 - 29, 2020
San Diego Convention Center
San Diego, California
Abstract submission deadline: Thursday, December 5
Advance registration deadline: Friday, December 20
Abstract Submission Opens: Tuesday, Sept. 24, 2019Abstract Submission Deadline: Thursday, Dec. 5, 2019, 11:59 p.m. ETLate-Breaking and Clinical Trials Abstract Submission Deadline: Thursday, Jan. 30, 2020, 11:59 p.m. ET
Guidelines for Preparation and Submission of Abstracts
AACR Abstract Submission SystemAuthors must submit abstracts for presentation at the Annual Meeting 2020 using the AACR Abstract Submission System, which will be available beginning Sept. 24, 2019. You can create, modify, and submit abstracts until the
Dec. 5, 2019, abstract deadline.
NEW in 2020Submit your abstract detailing how you use AACR Project GENIE data by the Dec. 5, 2019, deadline for an opportunity to be featured in a special session during the Annual Meeting 2020. Simply include GENIE as a keyword during the submission process.
The Abstract Submission System has been optimized for the
current versions of most browsers:
Responsibilities of AuthorsBy submitting an abstract for presentation at the AACR Annual Meeting, abstract authors agree and/or attest to the following:
Exception: Encore presentations are permitted for clinical trial abstracts that are submitted for the Jan. 30, 2020, clinical trial deadline. During the submission process, authors of encore clinical trial abstracts must provide the date and name of the meeting at which the original trial abstract was presented.
Content of AbstractsEach abstract should contain: (a) an introductory sentence indicating the purposes of the study; (b) a brief description of pertinent experimental procedures; (c) a summary of the new,
unpublished data; and (d) a statement of the conclusions.
Abstracts should be carefully proofread to avoid errors in the published literature. American spelling should be used
throughout; for more information regarding American spelling, please refer to Scientific Style and Format:
The CSE Manual for Authors, Editors, and Publishers, Eighth Edition (Council of Science
Abstract Control NumberAn Abstract Control Number (e.g., 19-A-1234-AACR) will be assigned to each abstract submitted online and will be listed on all email correspondence regarding the abstract. Please refer to the Abstract Control Number in any abstract communications.
Top of page
Financial Relationships of CoauthorsPer ACCME regulations, the AACR must collect information on the financial relationships of all meeting presenters and abstract authors. You will be asked to disclose your financial relationships and the financial relationships of each of your coauthors. Learn more about financial relationships.
Sponsor Permission and InformationEach abstract must be sponsored by an AACR member. You must secure the permission of the sponsor before submitting the abstract.
Learn more about abstract sponsorship regulations.
Length of AbstractsThe combined length of the abstract body, title, and tables may not exceed 2,600 characters, not including spaces and the author string. Tables count for 800 characters against the limit. Submission cannot be completed for abstracts that exceed this limit.
Abstract Category and SubclassificationYou must select a category and subclassification for your abstract. View categories and learn more.
Disclosure of Chemical Structures
At the time of abstract submission, the submitting author is required to state whether chemical compounds were used in the scientific work to generate the data in the proffered paper. Chemical compounds are defined as low-molecular-weight (generally <1000 g/mol) organic or inorganic molecules, peptides, or proteins/nucleic acids co-crystallized with low-molecular-weight molecules.
If chemical compounds were used, the corresponding author is further required to indicate whether the complete chemical structures of the compounds used will be disclosed at the time of presentation at the meeting. The chemical structures are not required to be included at the time of abstract submission; rather, an indication of the intent to disclose any such structures at the time of presentation is required.
The Program Committee will then evaluate the information provided by the corresponding author and determine the acceptability of the proffered paper for presentation. Those who do not intend to disclose chemical structures may have their abstracts rejected for participation; however, a limited number of these abstracts may be accepted for presentation if deemed to be of sufficient scientific merit.
Submission FeeEach abstract submitted must be accompanied by a $65 abstract submission fee. The submission fee can be paid by credit card or check. The fee is nonrefundable regardless of the final disposition of the abstract.
Abstract DeadlineThe deadline for abstract submissions is
11:59 p.m. U.S. ET, Thursday, Dec. 5, 2019. Abstracts submitted after the deadline will not be considered by the Program Committee. No changes may be made to abstracts after the Dec. 5, 2019, deadline.
Note: Submitting an abstract for presentation at the AACR Annual Meeting 2020 does not constitute registration for the meeting. Abstract presenters must register to attend the meeting by submitting the registration form or by registering online.
Late-Breaking Abstract Deadline The deadline for late-breaking abstracts is
11:59 p.m. U.S. ET, Thursday, Jan. 30, 2020. Abstracts detailing highly significant and timely findings in any area of cancer research that were not available at the time of the regular abstract deadline will be considered for presentation at the Annual Meeting. Only those abstracts that are deemed to be of high scientific priority will be accepted.
Abstract submission fees and sponsorship regulations alsoapply to late-breaking abstracts.
Clinical Trials Abstract Deadline All abstracts describing clinical trials (including placeholder abstracts) should be submitted as late-breaking abstracts. The deadline for clinical trials abstracts is
11:59 p.m. U.S. ET, Thursday, Jan. 30, 2020. Final data for placeholder abstracts are due
Thursday, Feb. 20, 2020.
Learn more about how to submit a Clinical Trials Abstract.
Abstract submission fees and sponsorship regulations alsoapply to clinical trials abstracts.
Publication OpportunityFor consideration of simultaneous publication in an AACR journal, please contact
Presentation of Proffered Papers at the AACR Annual MeetingEvery proffered abstract that has been accepted for publication in the
Proceedings must have a corresponding presentation at the meeting. Specifically, the author listed as the presenter for an accepted proffered paper must attend the corresponding session to discuss in detail the research outlined in the published abstract, according to the specific guidelines of the session. If, due to unforeseen circumstances, the designated presenter is unavailable to attend the session to present the paper, he or she must contact the AACR Program Development Department to designate a coauthor to serve as the presenter. If no abstract authors are available to present the data, they must withdraw the abstract immediately by contacting the AACR Program Development Department at (215) 440-9300 or
Failure to comply with these regulations pertaining to abstract presentation may result in actions including, but not limited to:
Deadline for Withdrawal of Abstracts
Requests to withdraw abstracts will be accepted through
Monday, March 9, 2020. Requests to withdraw late-breaking or clinical trials abstracts will be accepted through
Tuesday, March 24, 2020. Withdrawal requests must be sent by email to
firstname.lastname@example.org. Withdrawal requests must include the Abstract Control Number and title as well as an explanation of the reason for withdrawal.
Abstract Sponsorship Regulations
NEW in 2020: Expanded Abstract Sponsorship Privileges for AACR MembersThe AACR Board of Directors has approved an expansion of the abstract sponsorship privileges for selected AACR member types for the AACR Annual Meeting 2020, as outlined below: